Diana Ernst, RPh, Author at Renal and Urology News

Diana Ernst, RPh

Editorial Director
Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

All articles by Diana Ernst, RPh

Experts Weigh in on the Best Diets for 2020

The Mediterranean Diet was picked as the best diet overall for 2020, according to new rankings released by US News and World Report. An expert panel assessed 35 diets to come up with the final results, examining the evidence behind each diet’s claims. Specifically, they evaluated the likelihood of short-term and long-term weight loss, how…

Fetroja Approved for Complicated UTI in Patients With Limited or No Alternative Tx Options

The Food and Drug Administration (FDA) has approved Fetroja (cefiderocol; Shionogi) for the treatment of complicated urinary tract infections (cUTI), including pyelonephritis caused by the following susceptible Gram-negative microorganisms: Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, and Enterobacter cloacae complex. The treatment is indicated for patients aged ≥18 years with limited or no alternative…

Next post in Urinary Tract Infections (UTI)